Athos Therapeutics
About:
Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Website: https://athostx.com/
Twitter/X: athostx
Description:
Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Total Funding Amount:
$54.3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Torrance, California, United States
Founded Date:
2019-01-01
Founders:
Allan J. Pantuck, Dimitrios Iliopoulos, Michael Jung
Number of Employees:
11-50
Last Funding Date:
2024-02-16
IPO Status:
Private
© 2024 MyAiNote.com